Redefining Cardiometabolic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Redefining cardiometabolic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Redefining Cardiometabolic Today - Breaking & Trending Today

SGLT2 Inhibitors Could Reduce Risk of Lupus Nephritis and Dialysis in Systemic Lupus Erythematosus

A propensity score matched analysis suggests use of SGLT2 inhibitors could reduce risk of negative outcomes in patients with systemic lupus erythematosus and type 2 diabetes. ....

James Cheng Chung , Linkedin James Cheng Chung , Chung Shan Medical University Hospital , Hazard Ratio , Confidence Interval , Nephritis Among Patients With Systemic Lupus , Redefining Cardiometabolic ,

SMART-C Meta-Analysis: SGLT2 Inhibitors Reduce Cardiovascular Events

Meta-analysis of 11 phase 3 trials shows SGLT2 inhibitors reduce cardiovascular event risk by 9% across diverse patient populations. ....

George Institute For Global Health , Renal Trialist Consortium , Brendon Neuen , Research Fellow , George Institute , Analysis Cardio Renal Trialist Consortium , Hazard Ratio , Confidence Interval , Glucose Co Transporter , Major Adverse Cardiovascular Outcomes , Redefining Cardiometabolic ,

Empagliflozin Misses Primary Endpoint in Post-MI Patient Population, EMPACT-MI Trial

Results of EMPACT-MI suggest use of empagliflozin was not associated with a statistically significant reduction in a composite of death and heart failure hospitalization. ....

United States , Baylor Scott , Javed Butler , American College Of Cardiology , Institute Javed Butler , University Of Mississippi , American Heart Association , White Research Institute , American College , Annual Scientific Session , Dont Miss , Confidence Interval , After Acute Myocardial Infarction , Results Of The , Annual Scientific , Myocardial Infarction , Redefining Cardiometabolic , Show Mixed Results After Heart ,

A Silent Epidemic: Recognizing Chronic Kidney Disease as a Public Health Crisis

This installment in our Unprevented series examines the growing impact of chronic kidney disease on public health and what those in the field are doing to mitigate this growing crisis. ....

United States , Campbellp Finerenone Kerendia , Joseph Murray , Willem Kolff , Reubif Zur Geschichte , Kirsten Johansen , Joseph Vassalotti , Campbellp Empagliflozin Jardiance , Columbia University Medical Center , Kidney Equity For All Initiative , Transplantation Network , University Of Chicago Medicine George Bakris , Drug Administration , Chronic Disease Research Group At Hennepin Healthcare , University Of Chicago Medicine , National Kidney Foundation , American Society Of Hypertension Comprehensive Center , Centers For Disease , Clinical Development Program For Kerendia , Disease Control , Chicago Medicine , George Bakris , Global Burden , American Society , Comprehensive Hypertension Center , Hennepin Healthcare ,

Report: More than 25% of US Adults Has 1 or More Cardiac, Renal, or Metabolic Conditions

A 20-year analysis reveals over 25% of US adults have cardiac, renal, or metabolic conditions, with disparities in age and race. ....

John Ostrominski , Nutrition Examination Survey , National Health , Vascular Center , Saint Luke Mid America Heart Institute , White Research Institute , Hospital Heart , Saint Luke , Mid America Heart Institute , Hispanic Asian , Hispanic Black , Hispanic White , Metabolic Conditions , Redefining Cardiometabolic ,